Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Design Therapeutics (DSGN) Non Operating Income (2020 - 2021)

Design Therapeutics' Non Operating Income history spans 2 years, with the latest figure at $62000.0 for Q4 2021.

  • For Q4 2021, Non Operating Income rose 933.33% year-over-year to $62000.0; the TTM value through Dec 2021 reached $298000.0, up 496.0%, while the annual FY2025 figure was $9.7 million, 4.57% up from the prior year.
  • Non Operating Income for Q4 2021 was $62000.0 at Design Therapeutics, up from $19000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $166000.0 in Q1 2021 and bottomed at -$40000.0 in Q1 2020.